ClinicalTrials.gg
Drug

Elamipretide clinical trials

Also written MTP-131, Bendavia and Bendavia 10mg.

studies test it
28
open now
2
in phase 3
4
first study started
2010

How each study uses elamipretide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the elamipretide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Sept 2025 · FORZINITY · NDA 215244 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Elamipretide
16

Brand

Bendavia
9
Bendavia 10mg
2
Bendavia 50mg
2
Bendavia 100mg
1
FORZINITY
1

Development codes

MTP-131
18
SS-31
1

Studies by the year they started

28 studies that test it; most in 2016 (7)

Studies that test elamipretide, by start year
YearStudies
20101
20125
20131
20142
20154
20167
20172
20191
20222
20241
20262

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
14
Phase 3
4
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 1

Stealth BioTherapeutics Inc. (27) · Children's Hospital of Philadelphia (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test elamipretide, phase 3 first.

Studies

Open first, then newest update. How each study uses elamipretide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test elamipretide →

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call elamipretide · ClinicalTrials.gg INT004846

  • MeSH (NLM) C506540elamipretideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 87GWG91S09ELAMIPRETIDEConfirmed FDA, NLM, Wikidata
  • Wikidata Q27269822elamipretideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171874ElamipretideOne source FDA
  • DrugBank DB11981One source Wikidata

Also registered as elamipretide hydrochloride (UNII E40WZ3BK2D).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.